Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Dr. Martens plc

Market Cap 682M 903M 787M 725M 1.28B 85.13B 1.29B 8.63B 3.35B 41.95B 3.39B 3.32B 145B P/E 2027 *
14.3x
P/E 2028 * 11.5x
Enterprise Value 879M 1.16B 1.01B 935M 1.64B 110B 1.66B 11.12B 4.32B 54.04B 4.37B 4.27B 187B EV / Sales 2027 *
1.12x
EV / Sales 2028 * 1.03x
Free-Float
58.69%
Yield 2027 *
3.54%
Yield 2028 * 3.6%
1 day-1.04%
1 week+0.37%
Current month-2.46%
1 month+12.41%
3 months+16.87%
6 months-6.73%
Current year-5.83%
1 week 0.97
Extreme 0.97
0.98
1 month 0.88
Extreme 0.88
1
Current year 0.81
Extreme 0.8143
1.06
1 year 0.81
Extreme 0.8143
1.36
3 years 0.62
Extreme 0.618
2.04
5 years 0.62
Extreme 0.618
7.07
10 years 0.62
Extreme 0.618
7.25
Manager TitleAgeSince
Chief Executive Officer 55 2025-01-05
Director of Finance/CFO 53 2024-05-12
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 59 2020-12-31
Director/Board Member 53 2020-12-31
Director/Board Member 55 2025-07-09
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+0.37% - - 914M
+3.99%-4.08%+8.62%+29.48% 14.68B
+0.88%+2.58%-9.82% - 8.63B
+0.96%+0.06%+25.78%+18.87% 6.19B
-1.20%-5.87%-38.77%-34.60% 5.46B
-1.61%-4.62%+16.41%+28.69% 2.79B
-1.13%-1.32%-16.85%-18.66% 2.47B
+4.39%-15.00%-29.27% - 1.8B
+4.14%-1.28%+42.90%+19.87% 1.53B
+6.32%-3.13%+0.28%+27.62% 1.37B
Average +1.54%-0.93%-0.08%+10.18% 4.99B
Weighted average by Cap. +1.69%-1.22%+0.16%+13.42%

Financials

2027 *2028 *
Net sales 784M 1.04B 904M 833M 1.47B 97.76B 1.48B 9.91B 3.85B 48.18B 3.89B 3.81B 167B 822M 1.09B 948M 874M 1.54B 103B 1.55B 10.4B 4.04B 50.52B 4.08B 4B 175B
Net income 48.53M 64.24M 55.97M 51.6M 90.8M 6.05B 91.44M 614M 238M 2.98B 241M 236M 10.34B 60.18M 79.65M 69.4M 63.98M 113M 7.51B 113M 761M 296M 3.7B 299M 293M 12.82B
Net Debt 197M 260M 227M 209M 368M 24.53B 371M 2.49B 966M 12.09B 977M 956M 41.91B 165M 218M 190M 175M 309M 20.58B 311M 2.09B 810M 10.14B 820M 802M 35.15B
Logo Dr. Martens plc
Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company's segments include Europe, the Middle East and Africa (EMEA); Americas; and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Employees
2,377
Date Price Change Volume
26-06-17 0.9700 $ -1.04% 13,000
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
0.7050GBP
Average target price
1.002GBP
Spread / Average Target
+42.08%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!